Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404)
5,6-Dimethylxanthenone-4-acetic acid (DMXAA) acts through tumor vascular disruption and cytokine production and is the first of its class to enter phase 3 trials. We characterized leukocytes and cytokines in murine Colon 38 tumors before and after DMXAA treatment. Tumor mass declined 50% 24 hours af...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2009-08-01
|
| Col·lecció: | Neoplasia: An International Journal for Oncology Research |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S1476558609801358 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
